Experiment 440908
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | MALFETANO,JH: BLESSING,JA: JACOBS,AJ:. (1993). A PHASE II TRIAL OF DIDEMNIN B (NSC #335319) IN PATIENTS WITH PREVIOUSLY TREATED EPITHELIAL OVARIAN CANCER. A GYNECOLOGIC ONCOLOGY GROUP STUDY.. 16(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | 16 PATIENTS WITH ADVANCED OR RECURRENT EPITHELIAL OVARIAN CARCINOMA WERE USED IN THIS PHASE 2 STUDY. ALL PATIENTS HAD PRIOR CISPLATIN CONTAINING CHEMOTHERAPY. THERE WERE NO RESPONDERS TO TREATMENT. 7 PATIENTS HAD STABLE DISEASE AND 9 HAD INCREASING DISEASE. THE SIGNIFICANT TOXICITIES INCLUDED NAUSEA AND VOMITING. HEPATIC TOXICITY AND GRADE 4 HEPATIC TOXICITY. |
| Dose amount | 4.2 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |